CuB-mediated inhibition of β-catenin signaling further reduces the expression of MMP-2, Cyclin D1, MYC, Survivin and VEGF; and induces E-cadherin expression, thereby hindering the metastatic and stemness behavior of human NSCLC. Here, MYC is linked to non-small cell lung carcinoma.